{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T11:26:05Z","timestamp":1670498765948},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,2,22]],"date-time":"2018-02-22T00:00:00Z","timestamp":1519257600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s11060-018-2808-6","type":"journal-article","created":{"date-parts":[[2018,2,22]],"date-time":"2018-02-22T14:57:32Z","timestamp":1519311452000},"page":"391-399","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Validation of the Chowdhury overall survival score in patients with melanoma brain metastasis treated with Gamma Knife Radiosurgery"],"prefix":"10.1007","volume":"138","author":[{"given":"R. J.","family":"Rodenburg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. E.","family":"Hanssens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. K. Y.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. V.","family":"Beerepoot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,22]]},"reference":[{"key":"2808_CR1","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1002\/cncr.25634","volume":"117","author":"MA Davies","year":"2011","unstructured":"Davies MA, Liu P, McIntyre S, Kim KB, Papadopoulos N, Hwu WJ, Hwu P, Bedikian A (2011) Prognostic factors for survival in melanoma patients with brain metastases. Cancer 117:1687\u20131696","journal-title":"Cancer"},{"key":"2808_CR2","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s11912-013-0335-3","volume":"15","author":"V Gorantla","year":"2013","unstructured":"Gorantla V, Kirkwood JM, Tawbi HA (2013) Melanoma brain metastases: an unmet challenge in the era of active therapy. Curr Oncol Rep 15:483\u2013491","journal-title":"Curr Oncol Rep"},{"key":"2808_CR3","first-page":"25","volume":"4","author":"S Ramanujam","year":"2015","unstructured":"Ramanujam S, Schadendorf D, Long GV (2015) Systemic therapies for melanoma brain metastases: which drug for whom and when? Chin Clin Oncol 4:25","journal-title":"Chin Clin Oncol"},{"key":"2808_CR4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.rpor.2015.12.001","volume":"21","author":"J Nowak-Sadzikowska","year":"2016","unstructured":"Nowak-Sadzikowska J, Walasek T, Jakubowicz J, Blecharz P, Reinfuss M (2016) Current treatment options of brain metastases and outcomes in patients with malignant melanoma. Rep Pract Oncol Radiother 21:271\u2013277","journal-title":"Rep Pract Oncol Radiother"},{"key":"2808_CR5","first-page":"CD006121","volume":"9","author":"CG Patil","year":"2017","unstructured":"Patil CG, Pricola K, Sarmiento JM, Garg SK, Bryant A, Black KL (2017) Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases. Cochrane Database Syst Rev 9:CD006121","journal-title":"Cochrane Database Syst Rev"},{"key":"2808_CR6","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1186\/s13014-015-0553-y","volume":"10","author":"IH Chowdhury","year":"2015","unstructured":"Chowdhury IH, Ojerholm E, McMillan MT, Miller D, Kolker JD, Kurtz G, Dorsey JF, Nagda SN, Geiger GA, Brem S, O\u2019Rourke DM, Zager EL, Gangadhar T, Schuchter L, Lee JY, Alonso-Basanta M (2015) Novel risk scores for survival and intracranial failure in patients treated with radiosurgery alone to melanoma brain metastases. Radiat Oncol 10:248","journal-title":"Radiat Oncol"},{"key":"2808_CR7","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3171\/2010.5.JNS1014","volume":"114","author":"DN Liew","year":"2011","unstructured":"Liew DN, Kano H, Kondziolka D, Mathieu D, Niranjan A, Flickinger JC, Kirkwood JM, Tarhini A, Moschos S, Lunsford LD (2011) Outcome predictors of Gamma Knife surgery for melanoma brain metastases. J Neurosurg 114:769\u2013779 (Clinical article)","journal-title":"J Neurosurg"},{"key":"2808_CR8","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/S0360-3016(96)00619-0","volume":"37","author":"L Gaspar","year":"1997","unstructured":"Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhardt R (1997) Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745\u2013751","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2808_CR9","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.ijrobp.2009.08.025","volume":"77","author":"PW Sperduto","year":"2010","unstructured":"Sperduto PW, Chao ST, Sneed PK, Luo X, Suh J, Roberge D, Bhatt A, Jensen AW, Brown PD, Shih H, Kirkpatrick J, Schwer A, Gaspar LE, Fiveash JB, Chiang V, Knisely J, Sperduto CM, Mehta M (2010) Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys 77:655\u2013661","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2808_CR10","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1200\/JCO.2011.38.0527","volume":"30","author":"PW Sperduto","year":"2012","unstructured":"Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, Sneed PK, Chao ST, Weil RJ, Suh J, Bhatt A, Jensen AW, Brown PD, Shih HA, Kirkpatrick J, Gaspar LE, Fiveash JB, Chiang V, Knisely JP, Sperduto CM, Lin N, Mehta M (2012) Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 30:419\u2013425","journal-title":"J Clin Oncol"},{"key":"2808_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3171\/2013.9.JNS13788","volume":"120","author":"D Kondziolka","year":"2014","unstructured":"Kondziolka D, Parry PV, Lunsford LD, Kano H, Flickinger JC, Rakfal S, Arai Y, Loeffler JS, Rush S, Knisely JP, Sheehan J, Friedman W, Tarhini AA, Francis L, Lieberman F, Ahluwalia MS, Linskey ME, McDermott M, Sperduto P, Stupp R (2014) The accuracy of predicting survival in individual patients with cancer. J Neurosurg 120:24\u201330","journal-title":"J Neurosurg"},{"key":"2808_CR12","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/S0360-3016(00)00547-2","volume":"47","author":"LE Gaspar","year":"2000","unstructured":"Gaspar LE, Scott C, Murray K, Curran W (2000) Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 47:1001\u20131006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2808_CR13","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1001\/jama.1982.03320430047030","volume":"247","author":"FE Harrell Jr","year":"1982","unstructured":"Harrell FE Jr, Califf RM, Pryor DB, Lee KL, Rosati RA (1982) Evaluating the yield of medical tests. Jama 247:2543\u20132546","journal-title":"Jama"},{"key":"2808_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2288-13-33","volume":"13","author":"P Royston","year":"2013","unstructured":"Royston P, Altman DG (2013) External validation of a Cox prognostic model: principles and methods. BMC Med Res Methodol 13:33","journal-title":"BMC Med Res Methodol"},{"issue":"8","key":"2808_CR15","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrclinonc.2017.43","volume":"14","author":"JJ Luke","year":"2017","unstructured":"Luke JJ, Flaherty KT, Ribas A, Long GV (2017) Targeted agents and immunotherapies: optimizing outcomes in melanoma. Nat Rev Clin Oncol 14(8):463","journal-title":"Nat Rev Clin Oncol"},{"key":"2808_CR16","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/CJI.0000000000000159","volume":"40","author":"I Dagogo-Jack","year":"2017","unstructured":"Dagogo-Jack I, Lanfranchi M, Gainor JF, Giobbie-Hurder A, Lawrence DP, Shaw AT, Sullivan RJ (2017) A retrospective analysis of the efficacy of pembrolizumab in melanoma patients with brain metastasis. J Immunother 40:108\u2013113","journal-title":"J Immunother"},{"key":"2808_CR17","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1093\/annonc\/mdw417","volume":"27","author":"KA Ahmed","year":"2016","unstructured":"Ahmed KA, Abuodeh YA, Echevarria MI, Arrington JA, Stallworth DG, Hogue C, Naghavi AO, Kim S, Kim Y, Patel BG, Sarangkasiri S, Johnstone PA, Sahebjam S, Khushalani NI, Forsyth PA, Harrison LB, Yu M, Etame AB, Caudell JJ (2016) Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF\/MEK inhibitors, BRAF inhibitor, or conventional chemotherapy. Ann Oncol 27:2288\u20132294","journal-title":"Ann Oncol"},{"key":"2808_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ctrv.2016.08.003","volume":"50","author":"D Franceschini","year":"2016","unstructured":"Franceschini D, Franzese C, Navarria P, Ascolese AM, De Rose F, Del Vecchio M, Santoro A, Scorsetti M (2016) Radiotherapy and immunotherapy: Can this combination change the prognosis of patients with melanoma brain metastases? Cancer Treat Rev 50:1\u20138","journal-title":"Cancer Treat Rev"},{"key":"2808_CR19","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s11060-016-2072-6","volume":"127","author":"A Wolf","year":"2016","unstructured":"Wolf A, Zia S, Verma R, Pavlick A, Wilson M, Golfinos JG, Silverman JS, Kondziolka D (2016) Impact on overall survival of the combination of BRAF inhibitors and stereotactic radiosurgery in patients with melanoma brain metastases. J Neurooncol 127:607\u2013615","journal-title":"J Neurooncol"},{"key":"2808_CR20","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ejca.2017.01.007","volume":"75","author":"ES Choong","year":"2017","unstructured":"Choong ES, Lo S, Drummond M, Fogarty GB, Menzies AM, Guminski A, Shivalingam B, Clarke K, Long GV, Hong AM (2017) Survival of patients with melanoma brain metastasis treated with stereotactic radiosurgery and active systemic drug therapies. Eur J Cancer 75:169\u2013178","journal-title":"Eur J Cancer"},{"key":"2808_CR21","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1111\/jdv.12910","volume":"29","author":"M Pracht","year":"2015","unstructured":"Pracht M, Mogha A, Lespagnol A, Fautrel A, Mouchet N, Le Gall F, Paumier V, Lefeuvre-Plesse C, Rioux-Leclerc N, Mosser J, Oger E, Adamski H, Galibert MD, Lesimple T (2015) Prognostic and predictive values of oncogenic BRAF, NRAS, c-KIT and MITF in cutaneous and mucous melanoma. J Eur Acad Dermatol Venereol 29:1530\u20131538","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2808_CR22","doi-asserted-by":"publisher","first-page":"7149","DOI":"10.2147\/OTT.S119428","volume":"9","author":"M Chowdhary","year":"2016","unstructured":"Chowdhary M, Patel KR, Danish HH, Lawson DH, Khan MK (2016) BRAF inhibitors and radiotherapy for melanoma brain metastases: potential advantages and disadvantages of combination therapy. Onco Targets Ther 9:7149\u20137159","journal-title":"Onco Targets Ther"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-018-2808-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-018-2808-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-018-2808-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T00:55:55Z","timestamp":1550796955000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-018-2808-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,22]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["2808"],"URL":"https:\/\/doi.org\/10.1007\/s11060-018-2808-6","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,22]]},"assertion":[{"value":"14 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Conflict of interest"}}]}}